COMMUNIQUÉS West-GlobeNewswire

Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology

07/03/2018 - 13:00

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms [...]

Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference

07/03/2018 - 13:00

CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, [...]

Inovalon to Acquire ABILITY Network

07/03/2018 - 13:00

Combination Creates A Vertically Integrated Leader In Cloud-Based Enablement Of Data-Driven, Value-Based Care Accretive Transaction Accelerates Growth And Enhances Profitability Please refer to our Transaction [...]

BioVie Responds to Japan Patent Office and Comments on Recent Stock Price Decline

07/03/2018 - 13:00

BEVERLY, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that [...]

miRagen Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on March 14, 2018

07/03/2018 - 13:00

BOULDER, Colo., March 07, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Proteostasis Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference

07/03/2018 - 13:00

CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Axsome Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

07/03/2018 - 13:00

Interim analyses of STRIDE-1 and ADVANCE-1 trials of AXS-05 anticipated in 2018 Company to host conference call today at 8:00 AM Eastern NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: [...]

Trevena Reports Full Year 2017 Earnings

07/03/2018 - 13:00

– OLINVO™ (oliceridine) Injection New Drug Application submitted and accepted for review by FDA, with PDUFA date of November 2, 2018 – – Company to host conference call at 8:00 am EST today – CHESTERBROOK, Pa., March 07 [...]

Zomedica to Present at 30th Annual ROTH Conference

07/03/2018 - 12:55

ANN ARBOR, Mich., March 07, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the 30th [...]

PotNetwork Holding Inc.’s Diamond CBD Sets New Record For Monthly Online Sales with Over $500,000 in February Online Revenues Alone

07/03/2018 - 12:00

FT LAUDERDALE, Fla., March 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD Inc.com, achieved over $500,000 [...]

Tecan schedules Analyst and Media Conference on March 14 to discuss Full-Year 2017 Financial Results

07/03/2018 - 10:15

Männedorf, Switzerland, March 7, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference to discuss the full-year 2017 financial results on Wednesday, March 14, 2018 at 09:00 am CET [...]

NEXSTIM PLC PUBLISHES 2017 ANNUAL REPORT

07/03/2018 - 08:01

Company announcement, Helsinki, 7 March 2018 at 9:00 AM NEXSTIM PLC PUBLISHES 2017 ANNUAL REPORT Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a neuromodulation company developing and marketing pioneering [...]

DBV Technologies to Present at the Barclays Global Healthcare Conference

07/03/2018 - 07:31

Montrouge, March 7, 2018 DBV Technologies to Present at the Barclays Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that Susanna Mesa, [...]

DBV Technologies invitée à Présenter à la Barclays Global Healthcare Conference

07/03/2018 - 07:31

Montrouge, France, le 7 mars, 2018 (7H30 CET) DBV Technologies invitée à Présenter à la Barclays Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) annonce [...]

Novartis expands alliance with Science 37 to advance virtual clinical trials program

07/03/2018 - 07:16

Novartis and Science 37 commit to launch up to 10 trials with increasing decentralization over three years, scaling to "site-less" model Agreement builds on our long-standing investment in and collaboration with Science [...]

Bone Therapeutics Announces Private Placement of Convertible Bonds

07/03/2018 - 07:01

Regulated Information - Inside Information - 7 March 2018 - 7 am CET NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, [...]

Bone Therapeutics annonce un placement privé sous forme d'obligations convertibles:

07/03/2018 - 07:01

Information réglementée - Information confidentielle - 7 mars 2018 - 7h00 CET LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS- [...]

Mesoblast Enters Into US$75 Million Non-Dilutive Credit Facility

07/03/2018 - 01:31

MELBOURNE, Australia and NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced that it has entered into a US$75 million non-dilutive, four-year credit facility with [...]

Sonoma Pharmaceuticals Announces Closing of $5 Million Public Offering of Common Stock

07/03/2018 - 01:27

PETALUMA, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, Warrants – SNOAW) today announced the closing of a public offering of 1,428,570 shares of common stock at a public [...]